A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative determination of multiple makers associated with coagulation including coagulation factors, intermediates and/or their activated componen
| Company | Devices | Share |
|---|---|---|
| George King Bio-Medical, Inc | 32 | 17% |
| Medtronic, Inc. | 28 | 15% |
| Accriva Diagnostics Holdings, Inc. | 20 | 11% |
| Siemens Healthcare Diagnostics Products Gmbh | 14 | 8% |
| Instrumentation Laboratory Company | 13 | 7% |
| Fisher Diagnostics | 10 | 5% |
| Haemonetics Corporation | 9 | 5% |
| Bio-Rad Laboratories, Inc. | 8 | 4% |
| Helena Laboratories Corporation | 6 | 3% |
| Precision Biologic Inc | 5 | 3% |
| R 2 Diagnostics, Inc. | 5 | 3% |
| Eurotrol B.V. | 5 | 3% |
Company = labeler of record on GUDID. 24 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| GGN | Plasma, Coagulation Control | 98 |
| GGN | PLASMA, COAGULATION CONTROL | 35 |
| GGC | Control, Plasma, Abnormal | 19 |
| JBP | ACTIVATED WHOLE BLOOD CLOTTING TIME | 15 |
| JPA | SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES | 13 |
| GGC | CONTROL, PLASMA, ABNORMAL | 9 |
Use these as the dimensions to specify in a tender line.
184 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Multiple coagulation marker IVD, control", from 24 companies. The largest labeler is George King Bio-Medical, Inc with 17% of records.
GGN (Plasma, Coagulation Control), GGN (PLASMA, COAGULATION CONTROL), GGC (Control, Plasma, Abnormal), JBP (ACTIVATED WHOLE BLOOD CLOTTING TIME)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add multiple coagulation marker ivd, control to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.